Amacna, Caryl Jane E.
HRN: 21-09-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2026
METRONIDAZOLE 500MG (TAB)
01/24/2026
01/28/2026
PO
500
TID
THICKLY MSAF
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines